|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1301 Pennsylvania Ave NW |
Address2 | Suite 800 |
City | WASHINGTON |
State | DC |
Zip Code | 20004-1725 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 2811-12
|
||||||||
|
6. House ID# 305490000
|
TYPE OF REPORT | 8. Year | 2009 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Paul G. Billings, Vice President National Policy & Advocacy |
Date | 04/20/2009 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CAW
16. Specific lobbying issues
Issues related to the health impacts of air pollution, including the following legislation: HR 1 The American Recovery and Reinvestment Act; S.336 American Recovery and Reinvestment Act of 2009; HR 1105 Omnibus Appropriations Act, 2009; Department of the Interior, Environment, and Related Agencies Appropriations Act 2010;
Clean air issues related to mobile source emissions; fuels including alternative fuels; stationary source emissions, including power plants and implementation and enforcement of the Clean Air Act. Issues related to global warming.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Environmental Protection Agency (EPA), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Billings |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Issues related to the prevention and treatment of lung disease, including the following legislation: HR 2 Children's Health Insurance Program Reauthorization Act of 2009; S.275 Children's Health Insurance Program Reauthorization Act of 2009; HR 1 The American Recovery and Reinvestment Act; S.336 American Recovery and Reinvestment Act of 2009; HR 1105 Omnibus Appropriations Act, 2009;
HR 1619 Children's Health Protection Act of 2009; S 643 Children's Health Protection Act of 2009; HR 716 Access to Cancer Clinical Trials Act; S. 488 Access to Cancer Clinical Trials Act; HR 1850 Quit Smoking for Life Act; S. 770 Medicare, Medicaid, and MCH Tobacco Cessation Promotion Act of 2009; S. 717 21st Century Cancer ALERT (Access to Life-Saving Early detection, Research and Treatment) Act; HR 332 Lung Cancer Mortality Reduction Act of 2009; S 670 Smoke Free Mothers and Babies Act of 2009; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2010; Issues related to health care reform; Issues related to asthma; Issues related to chronic obstructive pulmonary disease; Issues related to lung cancer; Issues related to tuberculosis;
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Natl Institutes of Health (NIH)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Billings |
|
|
|
Erika |
Sward |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Issues related to lung disease treatment, prevention and research, public health and clean air including the following legislation: HR 1 The American Recovery and Reinvestment Act; S.336 American Recovery and Reinvestment Act of 2009; HR 1105 Omnibus Appropriations Act, 2009;
H.CON.RES.85 Setting forth the congressional budget for the United States Government for fiscal year 2010 and including the appropriate budgetary levels for fiscal years 2009 and 2011 through 2014;
S.CON.RES.13 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2010, revising the appropriate budgetary levels for fiscal year 2009, and setting forth the appropriate budgetary levels for fiscal years 2011 through 2014; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2010; Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2010; Department of the Interior, Environment, and Related Agencies Appropriations Act 2010; Department of State, Foreign Operations and Related Programs Appropriations Act, 2010;
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Disease Control & Prevention (CDC), Natl Institutes of Health (NIH), Environmental Protection Agency (EPA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Billings |
|
|
|
Erika |
Sward |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
Issues related to tobacco use prevention, cessation, secondhand smoke and product regulation including: HR 1256 Family Smoking Prevention and Tobacco Control Act; HR 2 Children's Health Insurance Program Reauthorization Act of 2009; S.275 Children's Health Insurance Program Reauthorization Act of 2009; HR 1 The American Recovery and Reinvestment Act; S.336 American Recovery and Reinvestment Act of 2009; HR 1105 Omnibus Appropriations Act, 2009;
HR 1261Youth Prevention and Tobacco Harm Reduction Act; S. 579 Federal Tobacco Act of 2009; HR 1432 Stop Adolescent Smoking Without Excessive Bureaucracy Act of 2009; HR 1850 Quit Smoking for Life Act; S 770 Medicare, Medicaid, and MCH Tobacco Cessation Promotion Act of 2009; H.R.1400 To amend title 39, United States Code, to make cigarettes and certain other tobacco products nonmailable, and for other purposes; HR 1676 Prevent All Cigarette Trafficking Act of 2009;
S 670 Smoke Free Mothers and Babies Act of 2009; Senate FDA Tobacco Regulation legislation; Framework Convention on Tobacco Control; Protecting federal workers from secondhand smoke; Tobacco use and the military;
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Disease Control & Prevention (CDC), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Billings |
|
|
|
Erika |
Sward |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Issues related to lung disease including tobacco tax
HR 2 Children's Health Insurance Program Reauthorization Act of 2009; S.275 Children's Health Insurance Program Reauthorization Act of 2009;
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Billings |
|
|
|
Erika |
Sward |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Issues related to the prevention and treatment of lung disease including the following legislation:HR 2 Children's Health Insurance Program Reauthorization Act of 2009; S.275 Children's Health Insurance Program Reauthorization Act of 2009; HR 1 The American Recovery and Reinvestment Act; S.336 American Recovery and Reinvestment Act of 2009; HR 1105 Omnibus Appropriations Act, 2009;
HR 1619 Children's Health Protection Act of 2009; HR 716 Access to Cancer Clinical Trials Act; S. 488 Access to Cancer Clinical Trials Act; HR 1850 Quit Smoking for Life Act; S. 770 Medicare, Medicaid, and MCH Tobacco Cessation Promotion Act of 2009; S. 717 21st Century Cancer ALERT (Access to Life-Saving Early detection, Research and Treatment) Act; HR 332 Lung Cancer Mortality Reduction Act of 2009; S 670 Smoke Free Mothers and Babies Act of 2009; Issues related to home oxygen; Issues related to health care reform;
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Billings |
|
|
|
Erika |
Sward |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code RET
16. Specific lobbying issues
Issues related to offsetting costs of tobacco regulation legislation:
HR 1804 Federal Retirement Reform Act of 2009; HR 1256 Family Smoking Prevention and Tobacco Control Act;
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Billings |
|
|
|
Erika |
Sward |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | 1301 Pennyslvania Avenue NW Suite 800 |
||||||
City | Washington |
State | |
Zip Code | 20004-1725 |
Country | |
21. Client new principal place of business (if different than line 20)
City | Washington |
State | |
Zip Code | 20004-1725 |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |